Diabetes Attitudes, Wishes and Needs second study (DAWN2™): Cross‐national benchmarking of diabetes‐related psychosocial outcomes for people with diabetes

Diabetic Medicine - Tập 30 Số 7 - Trang 767-777 - 2013
Antonio Nicolucci1, Katharina Kovacs Burns2, R. I. G. Holt3, Marco Comaschi4, Norbert Hermanns5, Hitoshi Ishii6, Andrzej Kokoszka7, Frans Pouwer8, Søren Skovlund9, Heather L. Stuckey10, İlhan Tarkun11, Michael Vallis12, Johan Wens13,14, Mark Peyrot15
1Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy
2Edmonton Clinic Health Academy University of Alberta Edmonton AB Canada
3University of Southampton, Southampton, UK
4Istituto Clinico Ligure di Alta Specialit GVM Care and Research Rapallo Italy
5Research Institute Diabetes Diabetes Zentrum Mergentheim Bad Mergentheim Germany
6Tenri Hospital Tenri Nara Japan
7Medical University of Warsaw, Warsaw, Poland
8Tilburg University, Tilburg, The Netherlands
9Novo Nordisk, Copenhagen, Denmark
10Penn State College of Medicine, Hershey, PA USA
11Kocaeli University, Kocaeli, Turkey
12Dalhousie University, Halifax, NS, Canada
13University of Antwerp *
14University of Antwerp, Antwerp, Belgium
15Loyola University Maryland, Baltimore, MD, USA

Tóm tắt

AbstractAimsThe second Diabetes Attitudes, Wishes and Needs (DAWN2) study aimed to assess psychosocial outcomes in people with diabetes across countries for benchmarking.MethodsSurveys included new and adapted questions from validated questionnaires that assess health‐related quality of life, self‐management, attitudes/beliefs, social support and priorities for improving diabetes care. Questionnaires were conducted online, by telephone or in person.ResultsParticipants were 8596 adults with diabetes across 17 countries. There were significant between‐country differences for all benchmarking indicators; no one country's outcomes were consistently better or worse than others. The proportion with likely depression [WHO‐5 Well‐Being Index (WHO‐5) score ≤ 28] was 13.8% (country range 6.5–24.1%). Diabetes‐related distress [Problem Areas in Diabetes Scale 5 (PAID‐5) score ≥ 40] was reported by 44.6% of participants (17.2–67.6%). Overall quality of life was rated ‘poor’ or ‘very poor’ by 12.2% of participants (7.6–26.1%). Diabetes had a negative impact on all aspects investigated, ranging from 20.5% on relationship with family/friends to 62.2% on physical health. Approximately 40% of participants (18.6–64.9%) reported that their medication interfered with their ability to live a normal life. The availability of person‐centred chronic illness care and support for active involvement was rated as low. Following self‐care advice for medication and diet was most common, and least common for glucose monitoring and foot examination, with marked country variation. Only 48.8% of respondents had participated in diabetes educational programmes/activities to help manage their diabetes.ConclusionsCross‐national benchmarking using psychometrically validated indicators can help identify areas for improvement and best practices to drive changes that improve outcomes for people with diabetes.

Từ khóa


Tài liệu tham khảo

10.1111/j.1365-2125.2010.03711.x

10.1016/j.diabres.2011.02.002

10.1111/j.1464-5491.2012.03727.x

10.2337/diaspect.18.3.136

10.1111/j.1464-5491.2005.01644.x

10.2337/diaclin.24.4.154

10.1002/pdi.648

10.1016/j.diabres.2012.11.016

International Alliance of Patients’ Organizations (IAPO).Patient‐Centred Healthcare Indicators Review.2012. Available athttp://www.patientsorganizations.org/attach.pl/1438/1332/PCHIndicators Review.pdf. Last accessed 13 May 2013.

10.1016/j.pec.2009.07.025

10.2337/dc07-0447

Snijders TAB, 1999, Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling

10.2337/diacare.27.2.398

10.1093/acprof:oso/9780195152968.001.0001

10.1111/dme.12242

10.1016/j.diabet.2010.08.004

10.1016/j.psym.2012.08.004

10.1007/s10865-011-9359-z

10.3111/13696998.2011.610852

10.2337/dc11-2103

10.4158/EP10398.OR

10.3122/jabfm.2010.02.090125

10.2337/dc10-2298

10.1016/j.diabet.2009.02.001

10.1007/s13300-011-0007-y

10.1111/j.1742-1241.2009.02277.x

10.1016/j.sapharm.2010.10.004

10.4093/dmj.2012.36.6.452

Thông tin
Thông tin xuất bản

Diabetic Medicine

Tập 30 Số 7

767-777

Thông tin tác giả